Related Experiment Video
Updated: Jul 7, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo
Julia K Kurash1, Hong Lei, Qiong Shen
1Epigenetics, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA.
Abstract:
The protein methyltransferase Set7/9 was recently shown to regulate p53 activity in cancer cells. However, the impact of Set7/9 on p53 function in vivo is unclear. To explore these issues, we created a null allele of Set7/9 in mice. Cells from Set7/9 mutant mice fail to methylate p53 K369, are unable to induce p53 downstream targets upon DNA damage, and are predisposed to oncogenic transformation. Importantly, we find that methylation of p53 by Set7/9 is required for the binding of the acetyltransferase Tip60 to p53 and for the subsequent acetylation of p53. We provide the first genetic evidence demonstrating that lysine methylation of p53 by Set7/9 is important for p53 activation in vivo and suggest a mechanistic link between methylation and acetylation of p53 through Tip60.
Insights
The protein methyltransferase Set7/9 is crucial for p53 activation in vivo. Its absence impairs DNA damage response and promotes cancer by preventing p53 methylation and subsequent acetylation.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- The protein methyltransferase Set7/9 (SET Domain Containing 7) has been implicated in regulating p53 activity within cancer cells.
- The in vivo significance of Set7/9 in modulating p53 function remains largely undetermined.
Purpose of the Study:
- To investigate the in vivo role of Set7/9 in p53 regulation and its implications for cancer development.
- To elucidate the mechanistic link between Set7/9-mediated methylation and p53 acetylation.
Main Methods:
- Generation of a Set7/9 null allele in mice to study its in vivo function.
- Analysis of p53 methylation and acetylation status in Set7/9 mutant cells.
- Assessment of p53 downstream target gene induction following DNA damage.
- Evaluation of oncogenic transformation predisposition in Set7/9 deficient cells.
Main Results:
- Set7/9 mutant mice cells exhibit a failure to methylate p53 at lysine 369 (K369).
- These cells demonstrate impaired induction of p53 target genes in response to DNA damage.
- Set7/9 deficiency leads to a predisposition towards oncogenic transformation.
- Methylation of p53 by Set7/9 is essential for the recruitment of the acetyltransferase Tip60 and subsequent p53 acetylation.
Conclusions:
- This study provides the first genetic evidence for the critical role of Set7/9-mediated lysine methylation in p53 activation in vivo.
- A mechanistic connection between p53 methylation by Set7/9 and its subsequent acetylation by Tip60 has been established.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...

